Launch HN: RonanRX (YC S26) – Personalized Peptides and GLP-1s
RonanRX, a startup from Y Combinator’s Summer 2026 batch, announced its launch on Hacker News. The company plans to offer customized peptide and GLP‑1 therapies, using data‑driven methods to tailor dosages for individual health goals. It aims to streamline access to these biologics through an online platform, targeting metabolic and weight‑management applications. The platform complies with U.S. medical regulations and ships products nationwide.